Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022
Upgrades
Benzinga ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
UNBELIEVABLE: Biolase - The Untold Story
Earnings Preview For Biolase
Biolase (NASDAQ:BIOL) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement.
Analysts estimate that Biolase will report an earnings per share (EPS) of $-0.68.
Benzinga ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
Benzinga
Organisations
Nasdaq
22,802 stories
NYSE
19,902 stories
Turning Point
225 stories
Novavax
210 stories
B of A Securities
173 stories
AllState
128 stories
Ross Stores
94 stories
Pure Storage
63 stories
Hewlett Packard
52 stories
Comerica
51 stories
Berenberg
39 stories
Ollie Bargain Outlet
30 stories
Freshpet
28 stories
Revolution Medicines
27 stories
Wixcom
19 stories
Citi Trends
16 stories
Dollar Gen
16 stories
Inspirato
14 stories
Trex Co
13 stories
ESAB
12 stories
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
